Sage Therapeutics Announces US Drug Enforcement Administration Scheduling of ZULRESSO™ (brexanolone) Injection - BioSpace

Submitted by Anonymous (not verified) on Fri, 06/14/2019 - 14:56

Sage Therapeutics Announces US Drug Enforcement Administration Scheduling of ZULRESSO™ (brexanolone) Injection  BioSpaceCAMBRIDGE, Mass.--(BUSINESS WIRE)-- SAGE Therapeutics (NASDAQ: SAGE), a biopharmaceutical company developing novel medicines to treat ...